Zobrazeno 1 - 10
of 368
pro vyhledávání: '"Perdrizet J"'
Autor:
Fridh AC; Access and Value, Pfizer AB, Stockholm, Sweden., Palmborg A; Medical and Scientific Affairs, Pfizer AB, Stockholm, Sweden., Ta A; Evidence Value and Access, Cytel, London, UK., Freigofaite D; Evidence Value and Access, Cytel, Rotterdam, Netherlands., Warren S; Global Value and Evidence, Vaccines, Pfizer Inc, New York, NY, USA., Perdrizet J; Global Value and Evidence, Pfizer Canada, Kirkland, Canada.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2400751. Date of Electronic Publication: 2024 Sep 15.
Autor:
Ta A; Cytel, London, United Kingdom., Kühne F; Pfizer Pharma GmbH, Berlin, Germany., Laurenz M; Pfizer Pharma GmbH, Berlin, Germany., von Eiff C; Pfizer Pharma GmbH, Berlin, Germany., Warren S; Pfizer Inc, New York City, New York, USA., Perdrizet J; Pfizer Canada, Kirkland, Quebec, Canada. Johnna.Perdrizet@pfizer.com.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Jun; Vol. 13 (6), pp. 1333-1358. Date of Electronic Publication: 2024 May 11.
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 791-803 (2018)
Dhvani Shah,1 Nancy A Risebrough,2 Johnna Perdrizet,1 Neeraj N Iyer,3 Cory Gamble,4 Tam Dang-Tan3 1ICON, Commercialisation and Outcomes, Health Economics, New York, NY, USA; 2ICON, Commercialisation and Outcomes, Health Economics, Toronto, ON, Canada
Externí odkaz:
https://doaj.org/article/3f0743c85cff40ef9fadbeb306375825
Autor:
Rozenbaum MH; Pfizer, Capelle a/d Ijssel, Netherlands. Electronic address: mark.rozenbaum@pfizer.com., Huang L; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Perdrizet J; Pfizer, Inc., New York, NY, United States., Cane A; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Arguedas A; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Hayford K; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Tort MJ; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Chapman R; Evidera, UK., Dillon-Murphy D; Evidera, UK., Snow V; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Chilson E; Medial Development & Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States., Farkouh RA; Pfizer, Inc., New York, NY, United States.
Publikováno v:
Vaccine [Vaccine] 2024 Jan 25; Vol. 42 (3), pp. 573-582. Date of Electronic Publication: 2024 Jan 07.
Autor:
Perdrizet J; Global Value and Evidence, Pfizer Canada, Kirkland, QC, Canada., Wilson M; RTI Health Solutions, Research Triangle Park, North Carolina, USA., Wannaadisai W; Global Value and Evidence, Pfizer Ltd, Tadworth, UK., Apodaca K; Vaccines, Global Medical Affairs, Pfizer Inc, New York, USA., Grant L; Vaccines, Global Medical Affairs, Pfizer Inc, New York, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 879-886. Date of Electronic Publication: 2024 Oct 09.
Autor:
Shinjoh M; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan., Togo K; Health and Value, Pfizer Japan Inc, Tokyo, Japan., Hayamizu T; Health and Value, Pfizer Japan Inc, Tokyo, Japan., Yonemoto N; Health and Value, Pfizer Japan Inc, Tokyo, Japan., Morii J; HEOR, Real World Evidence, IQVIA Solutions G.K, Tokyo, Japan., Perdrizet J; Global Value and Evidence, Pfizer Canada, Montreal, QC, Canada., Kamei K; Health and Value, Pfizer Japan Inc, Tokyo, Japan.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 485-497. Date of Electronic Publication: 2024 May 02.
Autor:
Patikorn C; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand., Kategeaw W; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA., Perdrizet J; Global Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Li X; Global Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Chaiyakunapruk N; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2177459. Date of Electronic Publication: 2023 Mar 07.
Autor:
Warren S; Global Health Economic and Outcomes Research, Pfizer Inc., New York, NY 10001, USA., Barmpouni M; Pfizer Hellas, 154 51 Athens, Greece., Kossyvaki V; Pfizer Hellas, 154 51 Athens, Greece., Gourzoulidis G; Health Through Evidence, 174 56 Athens, Greece., Perdrizet J; Global Health Economics and Outcomes Research, Pfizer Canada, Kirkland, QC H9J 2M5, Canada.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Aug 15; Vol. 11 (8). Date of Electronic Publication: 2023 Aug 15.
Autor:
Lytle D; Market Access, Pfizer Canada, Kirkland, QC, Canada., Grajales Beltrán AG; Vaccines Medical Affairs, Pfizer Canada, Kirkland, QC, Canada., Perdrizet J; Global Value and Evidence, Pfizer Canada, Kirkland, QC, Canada., Ait Yahia N; Market Access, Pfizer Canada, Kirkland, QC, Canada., Cane A; Vaccines Medical and Scientific Affairs, North America, Pfizer Inc, Collegeville, PA, USA., Yarnoff B; Modeling & Simulation,Evidera, Bethesda, MD, USA., Chapman R; Modeling & Simulation,Evidera, London, UK.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug; Vol. 19 (2), pp. 2257426. Date of Electronic Publication: 2023 Sep 29.
Autor:
Huang L; Patient and Health Impact, Pfizer Inc, 235 East 42nd Street, New York City, NY, 10017, USA. Liping.Huang@pfizer.com., Nguyen JL; Vaccines Medical Development and Scientific/Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Alfred T; Statistical Research and Data Science Center, Pfizer Inc, New York City, NY, USA., Perdrizet J; Patient and Health Impact, Pfizer Inc, 235 East 42nd Street, New York City, NY, 10017, USA., Cane A; Vaccines Medical Development and Scientific/Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Arguedas A; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2022 Dec; Vol. 11 (6), pp. 2141-2158. Date of Electronic Publication: 2022 Oct 10.